Library / Redox / Glutathione

γ-Glu-Cys-Gly · GSH

Glutathione

Endogenous tripeptide Variable protocols

ClassMaster intracellular antioxidant
Also used asPhase II conjugation cofactor
RoutesIV, IM, SC, inhaled, oral (poor intact absorption)
EvidenceBroad biochemical; indication-specific trials mixed

What it is

Glutathione is the cell’s primary thiol buffer: glutamate, cysteine, and glycine. It quenches reactive oxygen species via glutathione peroxidase and conjugates electrophiles via glutathione S-transferases.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Reduced GSH donates electrons and is recycled by glutathione reductase using NADPH. Raising extracellular glutathione does not automatically raise intracellular GSH; cells prefer precursor amino acids, especially cysteine availability.

Possible side effects / caveats

Generally discussed as well tolerated parenterally, with asthma-type reactions possible if inhaled in sensitive people, and rare rash or abdominal discomfort. Oral GSH is a different pharmacokinetic problem than an injectable research vial.

Protocol ranges

Source tierAmountCadenceNotes
Cited parenteral200–600 mgSeveral times per weekWellness-clinic style figures; not a universal standard
Cited higher IV1000–2000 mgSession-basedMedical/aesthetic clinic use; not a research-vial instruction